Taume
Taume News Taume Picturer Taume Mobile

Science news

STEC CellCare Technology Delivers Big Boost in 24 nm MLC NAND Flash Memory Endurance

STEC, Inc., a leading global provider of solid-state drive (SSD) technologies and products, today announced that the company has validated its proprietary CellCare Technology's ability to extend the endurance of 24 nm consumer-grade multi-level cell (cMLC) NAND flash memory to 40,000 program/erase cycles.

Celladon Closes Round with $53M

Celladon Corp., a biopharmaceutical company focused on the discovery and development of innovative treatments for cardiovascular diseases, announced the receipt of additional capital proceeds from a second close of its recent venture financing to advance the Company’s lead investigational product candidate MYDICAR® for the treatment of advanced heart failure.

Egalet Inks $14.3M Series B

Egalet Ltd., a privately held specialty pharmaceutical company focused on developing safe, effective and abuse-resistant medications, announced today that it has raised $14.3 million in a Series B financing round adding CLS Capital to the existing group of investors that includes Atlas Venture, Omega Funds, Sunstone Capital and Index Ventures.

MiRagen Therapeutics Raise $20M

MiRagen Therapeutics, Inc., a biopharmaceutical company developing innovative microRNA (miRNA)-based therapeutics primarily for the treatment of patients who suffer from cardiovascular and muscle disease, announced today the completion of a $20 million Series B financing.

OrbiMed Closes $222M Fund for Israel Life Sciences

OrbiMed, a leading global investment management firm focused on the healthcare sector, is pleased to announce the closing of its first investment fund dedicated to life sciences venture capital opportunities based in Israel.

Alder BioPharma Secures $38M Round

Alder BioPharmaceuticals Inc. today announced the closing of a $38 million Series D financing to support the development of the company’s clinical stage pipeline. The financing was led by a new investor, Novo Ventures, and joined by existing Alder investors Sevin Rosen Funds, Ventures West, WRF Capital, H.I.G. Ventures, Delphi Ventures and TPG Biotech.

SynGen Completes $5M Financing with Bay City Capital

SynGen Inc. a Regenerative Medicine device company focused on the development of next generation stem cell harvesting systems, announced today that it has completed a $5 million Series A preferred stock financing with Bay City Capital, LLC (BCC).

Harvest Power Raises $110 Million in Series C Financing

Harvest Power, a leader in harnessing the renewable energy, soil and fertilizer value from organic materials, today announced a $110 million financing. True North Venture Partners led the investment with American Refining and Biochemical, Inc. participating alongside existing investors including Kleiner Perkins Caufield & Byers (KPCB), DAG Ventures and Generation Investment Management among others.

OvaScience Secures $37 Million in Series B Financing

OvaScience™, a fertility company focused on the discovery, development and commercialization of novel treatments for infertility, today announced that it has completed a $37 million Series B financing. The financing was led by General Catalyst.

Genalyte completes $11.8 million Series B financing

Genalyte, Inc., a life sciences company developing and commercializing innovative next-generation multiplexing technology, today announced completion of an $11.8 million Series B financing. New investors Redmile Group and Claremont Creek Ventures and private investors from Genalyte’s Series A round participated in the Series B financing.

Relievant Medsystems Announces $30 Million Series Deries D

Relievant Medsystems, Inc., a privately held medical device company pioneering the therapeutic use of basivertebral nerve ablation for the treatment of chronic axial low back pain, announced today that it has secured $30 million in a Series D equity financing to advance and expand the Company’s worldwide clinical development programs.

Bluewater Bio Raises £22.5 Million from Ombu Group and Hermes GPE

Bluewater Bio International, the provider of innovative high-performance and highly cost-effective water and wastewater treatment technologies, is pleased to announce that it has completed a £22.5 million financing round.

Mobile to Play a Significant Role in Healthcare as GSMA Research Predicts mHealth Market to be Worth US$23 billion by 2017 Mobile to Play a Significant Role in Healthcare as GSMA Research Predicts mHealth Market to be Worth US$23 billion by 2017

Action from Governments, Regulators, the Healthcare Industry and the Mobile Ecosystem Essential to Enabling this Global Opportunity

Mayo Clinic Discovery Selected for Science’s Top 10 Achievements of 2011

The editors of the journal Science have selected a Mayo Clinic discovery as one of their top 10 "groundbreaking scientific achievements of 2011.

NASA’s Kepler Confirms Its First Planet in Habitable Zone of Sun-Like Star NASA’s Kepler Confirms Its First Planet in Habitable Zone of Sun-Like Star

NASA’s Kepler mission has confirmed its first planet in the "habitable zone" the region where liquid water could exist on a planet’s surface. Kepler also has discovered more than 1,000 new planet candidates, nearly doubling its previously known count.

Violent Video Games Alter Brain Function in Young Men

A functional magnetic resonance imaging (fMRI) analysis of long-term effects of violent video game play on the brain has found changes in brain regions associated with cognitive function and emotional control in young adult men after one week of game play. The results of the study were presented today at the annual meeting of the Radiological Society of North America(RSNA).

Understanding medical radiation: Siemens offers a new Internet-based information platform for the general public Understanding medical radiation: Siemens offers a new Internet-based information platform for the general public

There is a new information source for anyone facing an X-ray or a nuclear medicine examination. At medicalradiation.com, scientific journalists and experts from Siemens Healthcare provide basic details about medical radiation for the benefit of patients and interested members of the general public.

NASA's NPP Satellite Acquires First VIIRS Image NASA's NPP Satellite Acquires First VIIRS Image

The Visible Infrared Imager Radiometer Suite (VIIRS) onboard NASA's newest Earth-observing satellite, NPP, acquired its first measurements onNov. 21, 2011. This high-resolution image is of a broad swath of Eastern North America from Canada'sHudson Bay past Florida to the northern coast of Venezuela. The VIIRS data were processed at the NOAA Satellite Operations Facility (NSOF) in Suitland, Md.

Cancer-Causing Protein Strongly Tied to Hormone Resistance in Breast Cancer

In dozens of experiments in mice and in human cancer cells, a team of Johns Hopkins scientists has closely tied production of a cancer-causing protein called TWIST to the development of estrogen resistance in women with breast cancer.

Teen musicians in drug treatment win 2012 Grammy experience

Two teens with powerful stories about their experience in drug treatment have been awarded the top distinction in the MusiCares and Grammy Foundation’s Teen Substance Abuse Awareness through Music Contest.

 1  2  3  4  5
Latest News
Latest Galleries and Pictures
News By Topic
 ventures west   celladon   study   harvest power   rsna   cancer   sunstone capital   grammy   bay city capital   games   gsma   innovative   x-ray   treatment   cellcare technology   government   ssd   innovation   orbimed   fizer venture investors   acquire   scientist   heart   solutions   johns hopkins 
Privacy Statement  |  Terms of use  |  Tools  © TAUME.COM